Guides
When did a weight stall count as a plateau in a tirzepatide trial?
Short answer
In a post-hoc SURMOUNT-1 analysis, weight change below 5% over a 12-week interval counted as a plateau if every subsequent 12-week interval also stayed below that threshold. The first interval considered began at week 24. One week at the same weight does not meet this trial definition.1
Why do later measurements matter?
Imagine a 3% decrease from weeks 24 to 36 followed by a 6% decrease in the next interval. Looking back, the earlier interval would not qualify under the study rule. This hypothetical example illustrates why the definition depends on measurements from several trial visits.
Which participants were counted?
The analysis included 1,438 people from the tirzepatide groups of SURMOUNT-1. Criteria included receiving at least 75% of scheduled doses, losing at least 5% of body weight by the endpoint and having a weight measurement at week 72. The analysis therefore describes a subset of the original treatment groups.1
What do the figures of 24 to 36 weeks mean?
The middle time, or median, was 24.3 weeks in the overweight group and 36.1 weeks in the groups with class II and class III obesity. The selected groups and fixed measurement intervals limit what this tells you about an individual. At an appointment, you can ask over what period to assess your own trend.1
Primary sources
- SURMOUNT-1 and -4, original weight plateau analysis, sections 2 and 3
- SURMOUNT-1 trial registry record
Cite this page
Fastzuleicht · Editorial team. When did a weight stall count as a plateau in a tirzepatide trial? (18 November 2026). https://fastzuleicht.de/guides/weight-plateau-tirzepatide-trial/